| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| Company: Foresight Diagnostics |
| Recipient: You |
| Company: N Power |
| Recipient: You |
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Bayer |
| Recipient: You |
| Company: Gilead Sciences |
| Recipient: You |
| Company: Spectrum Pharmaceuticals |
| Recipient: You |
| Company: Abbvie |
| Recipient: You |
| Company: Celgene |
| Recipient: You |
| Company: Denovo Biopharma |
| Recipient: You |
| Company: BeiGene |
| Recipient: You |
| Company: Karyopharm Therapeutics |
| Recipient: You |
| Company: Pharmacyclics/Janssen |
| Recipient: You |
| Company: Genentech/Roche |
| Recipient: You |
| Company: Epizyme |
| Recipient: You |
| Company: Genmab |
| Recipient: You |
| Company: SeaGen |
| Recipient: You |
| Company: Foresight Diagnostics |
| Recipient: You |
| Company: Bristol-Myers Squibb/Celgene |
| Recipient: You |
| Company: Curio Sciences |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: MorphoSys |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Acerta Pharma |
| Recipient: Your Institution |
| Company: Janssen Oncology |
| Recipient: Your Institution |
| Company: Gilead Sciences |
| Recipient: Your Institution |
| Company: Celgene |
| Recipient: Your Institution |
| Company: TG Therapeutics |
| Recipient: Your Institution |
| Company: Genentech/Roche |
| Recipient: Your Institution |
| Company: Pharmacyclics |
| Recipient: Your Institution |
| Company: Abbvie |
| Recipient: Your Institution |
| Company: Millennium |
| Recipient: Your Institution |
| Company: Allogene |
| Recipient: Your Institution |
| Company: Xencor |
| Recipient: Your Institution |
| Company: 4D Pharma |
| Recipient: Your Institution |
| Company: Adaptimmune |
| Recipient: Your Institution |
| Company: Amgen |
| Recipient: Your Institution |
| Company: Bayer |
| Recipient: Your Institution |
| Company: Cellectis |
| Recipient: Your Institution |
| Company: EMD |
| Recipient: Your Institution |
| Company: Guardant Health |
| Recipient: Your Institution |
| Company: Iovance Biotherapeutics |
| Recipient: Your Institution |
| Company: Kite/Gilead |
| Recipient: Your Institution |
| Company: MorphoSys |
| Recipient: Your Institution |
| Company: Nektar |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: Sanofi |
| Recipient: Your Institution |
| Company: Takeda |
| Recipient: Your Institution |
| Company: ZIOPHARM Oncology |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|